Objectives: To perform molecular epidemiology for 113 KPC-producing Klebsiella pneumoniae isolated in 2010 from 12 Brazilian states.
Introduction
The most important mechanism of resistance against carbapenems in Enterobacteriaceae is the production of carbapenemases such as Klebsiella pneumoniae carbapenemase (KPC). This enzyme was first described in a K. pneumoniae strain isolate from the USA in 1996 1 and has been responsible for many outbreaks worldwide. 2 In addition to being resistant to all b-lactams available, this carbapenemase has a high capacity to spread, since its gene has been described in transferable plasmids and transposons such as Tn4401 associated with insertion sequence (IS) elements. 3 KPC-producing K. pneumoniae was first described as occurring in Brazil in 2006 4 and since then its incidence has greatly increased. 5 Seki et al. 5 observed the presence of the bla KPC-2 gene in K. pneumoniae strains isolated in five states from 2006 through to 2009. In 2010, however, a great dispersion of this gene was observed in this country, with the spread of carbapenem-resistant K. pneumoniae observed in several hospitals in different Brazilian cities and states.
Thus, the aim of this study was to perform molecular typing, determine the antimicrobial resistance profile and identify the carrier plasmid and the flanking region of the bla KPC gene of 113 KPC-producing K. pneumoniae from 32 hospitals located in 12 Brazilian states belonging to the five different geographical regions of this country in 2010.
Materials and methods

Bacterial isolates and phenotypic tests
Our laboratory (LAPIH), located at Instituto Oswaldo Cruz-FIOCRUZ, Ministry of Health, Brazil, routinely receives clinical bacterial isolates from hospitals and LACENs (Central Laboratory of Public Health) from different states. According to the clinical specimens (such as blood, urine, abdominal fluid and lower respiratory tract secretions) and locality [south (SC), south-east (ES, RJ and MG), north-east (PE, AL, CE, PI and MA), north (AM) and mid-west (GO and DF)], we selected 113 nonduplicate K. pneumoniae isolates among the 500 KPC-producing strains received in 2010. Bacteria were identified by conventional techniques 6 and identification of KPC allele variants was performed by PCR and sequencing. 5 Antimicrobial susceptibility testing was performed by the disc diffusion method 7 and Etest (AB Biodisk, Solna, Sweden). 
Molecular investigations
For molecular typing and epidemiological analysis we used PFGE 9 and multilocus sequence typing (MLST). 10 The genetic environment of the bla KPC-2 gene was investigated by PCR as described previously by Naas et al., 3 except for amplification of ISKpn7, in which the primers described by Kitchel et al. 11 were used. Using multiplex PCR, we analysed the plasmid incompatibility groups present in the different MLST types according to the scheme proposed by Carattoli et al.
12
The plasmids were extracted by alkaline lysis, 13 and the Southern blot hybridizations 14 were performed with digoxigenin-labelled bla KPC-2 and plasmid incompatibility group probes generated by the PCR DIG detection system (Roche Diagnostics).
Results and discussion
The majority of the 113 isolates were recovered from patients from the south-east (n¼ 46) and mid-west (n ¼42) regions, mainly the Federal District (38/113, 34%) and Rio de Janeiro state (28/113, 25%) ( Figure 1 ). Most of the isolates were recovered from blood (46/113, 41%) and urine (37/113, 33%). All isolates possessed the KPC-2 allele variant.
According to CLSI 2011 breakpoints, 7 most of the isolates were resistant to b-lactams, such as cefotaxime (93.8%), ceftazidime (87.6%) and piperacillin/tazobactam (100%). All isolates were non-susceptible to ertapenem (MIC 50 .32 mg/L, MIC range 2-.32 mg/L), 99.1% to imipenem (MIC 50 .32 mg/L, MIC range 1-.32 mg/L) and 99.1% to meropenem (MIC 50 .32 mg/L, MIC range 0.5 -.32 mg/L). We observed elevated resistance to ciprofloxacin (94.6%) and sulfamethoxazole/trimethoprim (85.4%), whereas 68/113 (60.2%), 47/113 (41.6%) and 6/113 (5.3%) were resistant to gentamicin, amikacin and fosfomycin trometamol, respectively. According to EUCAST 2011 breakpoints, A high level of resistance to different antimicrobial classes has frequently been observed in KPC-producing isolates worldwide. 2 Resistance to polymyxin and tigecycline is very worrisome, because these antimicrobials have been the last option for treatment of severe infections caused by KPC-producing organisms. According to Endimiani et al., 15 fosfomycin demonstrates in vitro activity against KPC-producing K. pneumoniae isolates and represents a possible alternative to polymyxin and tigecycline as a salvage therapy. Figure 1 shows the distribution of the 22 PFGE clones observed in the 113 KPC-producing K. pneumoniae for each Brazilian state. Despite the clonal diversity observed, the most prevalent profiles were A/Kp-RJ (28%), C (29%) and Q (13%). About 70% of polymyxin-and tigecycline-resistant strains belonged to clones A/Kp-RJ and C (polymyxin: A/Kp-RJ¼ 4, C¼ 4; tigecycline: A/Kp-RJ¼ 20, C¼ 10).
MLST performed on 39 isolates representing all PFGE clones, including isolates from each state, also found 22 sequence types (STs), showing great consistency between the two methodologies used (Figure 1 ). Thirteen new STs were first described in our study and were deposited in the K. pneumoniae MLST (ST755, ST756, ST757, ST758, ST759, ST760, ST837,  ST838, ST839, ST840, ST841, ST842 and ST855) . The most prevalent PFGE profiles were designated by MLST as A/Kp-RJ/ST437, C/ST11 and Q/ST340. ST11 and ST340 were reported in Greece. 16 In our previous report that considered isolates during the years 2006 -09, 5 we found ST437 in the south-east region (RJ and ES) and ST11 in the north-east and south-east (PE and MG). The current study reports the dispersion of these clones to different regions, with ST437 now being found in the south (SC), south-east (ES and RJ) and north-east (CE) regions. The ST11 and ST340 clones were found in the mid-west, south-east and north-east regions (ST11 in CE, DF, GO, MG, PE, RJ and ST340 in AL, DF, ES, PI). Andrade et al. Phylogenetic analysis showed that all these STs belong to the CC11 (where CC stands for clonal complex), which is widespread worldwide and includes the epidemic clone ST258. Two other clones first described in our study also belong to this CC: ST757 and ST855. All these clones were considered single locus variants, displaying differences in the tonB gene. Therefore, we found CC11 strains dispersed in 10 of the 12 Brazilian states studied (AL, CE, DF, ES, GO, PE, RJ and SC), comprising 75% of isolates. This study confirms that CC11 should be considered the most important CC related to bla KPC gene dispersion worldwide. 18 Two other CCs were found in our isolates: CC16-17 (ST16 and ST17) and CC758-840 (ST758 and ST840). ST16 was previously described in Canada, in strains producing NDM-1. 19 ST17 has already been observed in KPC-2-producing K. pneumoniae from Greece. 16 We found the bla KPC-2 gene is associated with Tn4401, variant 'b', in all strains tested (n¼39) ( Table 1) . This isoform has already been observed in the USA, 11 Greece 16 and Colombia. 20 In Brazil, previous reports observed the Tn4401 variants 'a' and 'b' associated with KPC-2-producing organisms of ST11, ST258 and ST437. 17, 20 The inverted repeat sequences of the flanking region were not amplified, suggesting that the insertion site found in our isolates may be different from that of K. pneumoniae YC of Naas et al.
3 ISKpn7 was observed in 84.6% (33/39) of the isolates, being absent from three isolates of ST11, two of ST138 and one of ST340. The lack of this IS suggests that another transposition event might have occurred.
The size of the plasmids carrying the bla KPC-2 gene varied between 3 and 60 kb, with the most prevalent being 40 kb (24%). In just one isolate of ST17 it was not possible to observe the bla KPC-2 gene associated with plasmids. Incompatibility group analysis of these plasmids revealed that in 14 isolates (36%) belonging to different STs (ST11, ST16, ST340, ST437, ST756, ST758, ST760, ST838, ST839, ST855), the bla KPC-2 gene was associated with 40 kb IncN plasmids; in the other 24 isolates we could not identify the incompatibility group of the bla KPC -carrying plasmids (Table 1) . Andrade et al. 17 found IncN (40 kb), IncL/M (50 -60 kb) and IncFII (130 kb) plasmids associated with the bla KPC-2 gene of ST11, ST437 and ST258 in Brazil. In one global study that included six countries, the bla KPC-2 gene was also found associated with plasmids of IncN (35, 70, 75 and 80 kb), IncL/M (12, 35 and 75 kb) and IncFII (80 kb). 20 
Conclusions
In Brazil, we believe the spread of the bla KPC-2 gene is occurring due to the dispersion of Tn4401 'b', carried and spread by strains of different STs. We described 13 new STs, however, a great dispersion of CC11 isolates, mainly A-KpRJ/ST437 and C/ST11, carrying IncN plasmids of 40 kb were observed. Thus, the spread of KPC carbapenemase may be facilitated by its localization on plasmids and transposons and also by efficient clones.
